Something I posted on "another board"....
Market capture is critical. Getting the word out that this drug is available either through (E)IND, compassionate use, or clinical trial is critical. I just found out this evening that one of my childhood friends has surrendered his fate to God after battling 15 years of cancer and four rounds of chemo. He has three beautiful and smart young daughters, a loving wife doing everything she can to hold it together, and a huge group of friends that are doing everything they can do to make his limited presence in this life more comfortable. He's a fighter but feels that another round of chemo will be the end. I've forwarded him NP and DrJ's info to share with his oncologist in hope that he might be a candidate for Leronlimab treatment.
I ask anyone who wishes - please pray for him - his name is Mike.
But cancer affecting millions isn't the only pestilence that Leronlimab can hopefully resolve. For just HIV, there are approx 38 million infected and about 1.7 million being added every year. If CYDY were able to touch only 10% of that it would be almost 4 million individuals whose lives would be remarkably improved. They would be able to lead more normal lives, their families and friends would be able to share in their presence on this earth leading a longer and more fruitful life.
As investors we have a moral prerogative to support and defend CytoDyn to allow them to bring Leronlimab to those most in need.
Time to double down and share the news with everyone in our circles of influence. Facebook, LinkedIn, etc - post what you can in language that your audience can understand. Dr. Yo has some wonderful videos. Some of the Proactive videos are helpful too. CytoDyn Updates on YouTube is full of informative videos.
I'm not suggesting that you convince anyone to invest in the company, but just to know that Leronlimab exists, it's on the horizon, and to ensure that it's given a fair playing field for being accessible to those in need.
So, do you know anyone with any of the following conditions that are potential indications that Leronlimab can possibly improve and extend their lives?
We can do this. Get the word out.
Again, here is a list of possible conditions that Leronlimab can help.
How many more "Gandhi" or "Einsteins" or "fill-in-the-blank-individuals" would be able to contribute to making our world a better place.
Allergies (anaphylactic shock)
Alzheimer's
Asthma
Atherosclerosis
Atopic Dermatitis
Cancer
Coeliac Disease
Chronic Fatigue Syndrome
Chronic Kidney Disease (underlying pathologies)
COPD
COVID-19 (and other coronaviruses)
Crohn's Disease
Colitis
Dermatomyositis
Diabetes (type 1 and 2)
Duchenne Muscular Dystrophy (possibly other muscular dystrophies also)
Emphysema
Fibromyalgia
Grave’s Disease
Guillain-Barre Syndrome
GVHD
Hashimoto’s Thyroiditis
Hepatitis (autoimmune)
HIV
Idiopathic Pulmonary Fibrosis
Inflammatory Bowel Disease
Influenza (severe)
Kawasaki Syndrome
Lambert-Eaton Syndrome
Lupus
Marshall’s syndrome (PFAPA)
Multiple Sclerosis
Myasthenia Gravis
Myocarditis
NASH
Neurofibromatosis
Parkinson's Disease
Pemphigus
Pneumonia
Polymyositis
Post-Myocardial Infarction Syndrome
Psoriasis
Rheumatic Fever
Rheumatoid Arthritis
Sarcoidosis
Scleroderma
Sickle Cell Disease (anti-inflammatory effect)
Sjogren’s Syndrome
Stroke
Tuberculosis
Vasculitis
Market capture is critical. Getting the word out that this drug is available either through (E)IND, compassionate use, or clinical trial is critical. I just found out this evening that one of my childhood friends has surrendered his fate to God after battling 15 years of cancer and four rounds of chemo. He has three beautiful and smart young daughters, a loving wife doing everything she can to hold it together, and a huge group of friends that are doing everything they can do to make his limited presence in this life more comfortable. He's a fighter but feels that another round of chemo will be the end. I've forwarded him NP and DrJ's info to share with his oncologist in hope that he might be a candidate for Leronlimab treatment.
I ask anyone who wishes - please pray for him - his name is Mike.
But cancer affecting millions isn't the only pestilence that Leronlimab can hopefully resolve. For just HIV, there are approx 38 million infected and about 1.7 million being added every year. If CYDY were able to touch only 10% of that it would be almost 4 million individuals whose lives would be remarkably improved. They would be able to lead more normal lives, their families and friends would be able to share in their presence on this earth leading a longer and more fruitful life.
As investors we have a moral prerogative to support and defend CytoDyn to allow them to bring Leronlimab to those most in need.
Time to double down and share the news with everyone in our circles of influence. Facebook, LinkedIn, etc - post what you can in language that your audience can understand. Dr. Yo has some wonderful videos. Some of the Proactive videos are helpful too. CytoDyn Updates on YouTube is full of informative videos.
I'm not suggesting that you convince anyone to invest in the company, but just to know that Leronlimab exists, it's on the horizon, and to ensure that it's given a fair playing field for being accessible to those in need.
So, do you know anyone with any of the following conditions that are potential indications that Leronlimab can possibly improve and extend their lives?
We can do this. Get the word out.
Again, here is a list of possible conditions that Leronlimab can help.
How many more "Gandhi" or "Einsteins" or "fill-in-the-blank-individuals" would be able to contribute to making our world a better place.
Allergies (anaphylactic shock)
Alzheimer's
Asthma
Atherosclerosis
Atopic Dermatitis
Cancer
Coeliac Disease
Chronic Fatigue Syndrome
Chronic Kidney Disease (underlying pathologies)
COPD
COVID-19 (and other coronaviruses)
Crohn's Disease
Colitis
Dermatomyositis
Diabetes (type 1 and 2)
Duchenne Muscular Dystrophy (possibly other muscular dystrophies also)
Emphysema
Fibromyalgia
Grave’s Disease
Guillain-Barre Syndrome
GVHD
Hashimoto’s Thyroiditis
Hepatitis (autoimmune)
HIV
Idiopathic Pulmonary Fibrosis
Inflammatory Bowel Disease
Influenza (severe)
Kawasaki Syndrome
Lambert-Eaton Syndrome
Lupus
Marshall’s syndrome (PFAPA)
Multiple Sclerosis
Myasthenia Gravis
Myocarditis
NASH
Neurofibromatosis
Parkinson's Disease
Pemphigus
Pneumonia
Polymyositis
Post-Myocardial Infarction Syndrome
Psoriasis
Rheumatic Fever
Rheumatoid Arthritis
Sarcoidosis
Scleroderma
Sickle Cell Disease (anti-inflammatory effect)
Sjogren’s Syndrome
Stroke
Tuberculosis
Vasculitis
6
